Senior insider sale
See Remarks at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$270.6K
5.77K shares
What this filing means
PINION JOHN RICHARD plans to sell 5.77K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $270.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/18/2023ACC: 0001950047-23-000769
Officer· See Remarks
Since Mar 2026
5.77K
Shares to sell
$270.6K
Approx. market value
2.01K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
7/16/2019
1.23KRestricted Stock
Not Applicable
7/16/2018
786.00Total acquired2.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/16/2019 | Restricted Stock Not Applicable | 1.23K | — |
7/16/2018 | Restricted Stock Not Applicable | 786.00 | — |
| Total | 2.01K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.75K
Market value
$170.0K
3/1/2023
Planned — Approximate Date
NASDPlanned
Units to sell
2.01K
Market value
$100.6K
5/18/2023
Total
Units
5.77K
Value
$270.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/1/2023 | 3.75K | $170.0K | — | Completed |
| Planned — Approximate Date | ||||
5/18/2023 | 2.01K | $100.6K | NASD | Planned |
| Total | 5.77K | $270.6K | ||